English

BIOETHICS LTD

EDGAR

BIOE Annual report (10-K) · filed 2025-08-13

Annual consolidated revenue for 2024: about USD 0, using the latest reported figures. The previous period, 2023, was about USD 0.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-72.2 thousand USD

2024 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -150429 USD Source
Operating Cash Flow: -78190 USD Source

Cash and cash equivalents: 14.7 thousand USD 2024-12-31 Source
Exact value

14664 USD
Long-term debt including current maturities: Not available
Shares outstanding: 3.34 million shares 2024-12-31 Source
Exact value

3335194 shares

Reported share-count change

193.80% · 2.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1135194 shares · 2023-12-31· Source
3335194 shares · 2024-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Revenue: 0 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 0 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 0 USD · 2024-07-01 – 2024-09-30 Source
Revenue: 0 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 0 USD · 2024-01-01 – 2024-09-30 Source

Net income

-177 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Net income: -39653 USD · 2024-01-01 – 2024-03-31 Source
Net income: -35932 USD · 2024-04-01 – 2024-06-30 Source
Net income: -53083 USD · 2024-07-01 – 2024-09-30 Source
Net income: -176955 USD · 2024-01-01 – 2024-12-31 Source
Net income: -128668 USD · 2024-01-01 – 2024-09-30 Source

Operating cash flow

-150 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Operating cash flow: -5895 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -38920 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -5895 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -78190 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -38920 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -150429 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -78190 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-13.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2024-12-31
Operating income: 8 of 11 periods available· newest 2024-12-31
Net income: 7 of 11 periods available· newest 2024-12-31
Operating cash flow: 11 of 11 periods available· newest 2024-12-31
capital expenditure: No compatible figures in this window
Total assets: 8 of 11 periods available· newest 2024-12-31
Total liabilities: 8 of 11 periods available· newest 2024-12-31
Current assets: 8 of 11 periods available· newest 2024-12-31
Current liabilities: 8 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2023-01-01 – 2023-12-31
Current period

USD 0

2024-01-01 – 2024-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
0 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOETHICS LTD · 2024-12-31 BIOETHICS LTD (edgar:894560) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#302063 Filing: 000147793225005771 Input fundies:Revenue: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#302689 Filing: 000147793225005771
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 79,806

Prior period

−USD 97,149

2023-01-01 – 2023-12-31
Current period

−USD 176,955

2024-01-01 – 2024-12-31

Exact inputs and evidence

-176955 − -97149 = -79806 USD

-97149 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-176955 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOETHICS LTD · 2024-12-31 BIOETHICS LTD (edgar:894560) Year-over-year change in Net income: -79806 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -176955 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#521190 Filing: 000147793225005771 Input fundies:NetIncome: -97149 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#521720 Filing: 000147793225005771
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 128,122

Prior period

−USD 22,307

2023-01-01 – 2023-12-31
Current period

−USD 150,429

2024-01-01 – 2024-12-31

Exact inputs and evidence

-150429 − -22307 = -128122 USD

-22307 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-150429 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOETHICS LTD · 2024-12-31 BIOETHICS LTD (edgar:894560) Year-over-year change in Operating cash flow: -128122 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -150429 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#443546 Filing: 000147793225005771 Input fundies:OperatingCashFlow: -22307 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#444227 Filing: 000147793225005771
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 0
Operating costs Derived USD 122,817
Operating income −USD 122,817
Tax, interest and other Derived USD 54,138
Net income −USD 176,955

Cash

Operating cash flow −USD 150,429
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	53981 Derived	-53981	19558 Derived	-73539	Unavailable	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -53981 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -73539 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -43946 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	70033 Derived	-70033	Unavailable	Unavailable	Unavailable	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -70033 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -79251 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	75141 Derived	-75141	Unavailable	Unavailable	Unavailable	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -75141 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -68694 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	59367 Derived	-59367	Unavailable	Unavailable	Unavailable	Source 2021-01-01 – 2021-12-31: 0 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -59367 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -27483 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	47303 Derived	-47303	Unavailable	Unavailable	Unavailable	Source 2022-01-01 – 2022-12-31: 0 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -47303 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -25639 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	50442 Derived	-50442	46707 Derived	-97149	Unavailable	Source 2023-01-01 – 2023-12-31: 0 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -50442 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -97149 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -22307 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	122817 Derived	-122817	54138 Derived	-176955	Unavailable	Source 2024-01-01 – 2024-12-31: 0 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -122817 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -176955 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -150429 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2024

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20142014-12-31	Revenue	Revenue: 0 Open source
20182018-12-31	Revenue	Revenue: 0 Open source
20192019-12-31	Revenue	Revenue: 0 Open source
20202020-12-31	Revenue	Revenue: 0 Open source
20212021-12-31	Revenue	Revenue: 0 Open source
20222022-12-31	Revenue	Revenue: 0 Open source
20232023-12-31	Revenue	Revenue: 0 Open source
20242024-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20222022-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20242024-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	Not reported	Operating Income: -18568 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -53981 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -70033 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	Not reported	Operating Income: -75141 Open source Revenue: 0 Open source
20212021-12-31	Operating margin	Not reported	Operating Income: -59367 Open source Revenue: 0 Open source
20222022-12-31	Operating margin	Not reported	Operating Income: -47303 Open source Revenue: 0 Open source
20232023-12-31	Operating margin	Not reported	Operating Income: -50442 Open source Revenue: 0 Open source
20242024-12-31	Operating margin	Not reported	Operating Income: -122817 Open source Revenue: 0 Open source
20142014-12-31	Net margin	Not reported	Net Income: -208191 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -73539 Open source Revenue: 0 Open source
2019-12-31	Net margin	Not reported	Revenue: 0 Open source
2020-12-31	Net margin	Not reported	Revenue: 0 Open source
2021-12-31	Net margin	Not reported	Revenue: 0 Open source
2022-12-31	Net margin	Not reported	Revenue: 0 Open source
20232023-12-31	Net margin	Not reported	Net Income: -97149 Open source Revenue: 0 Open source
20242024-12-31	Net margin	Not reported	Net Income: -176955 Open source Revenue: 0 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -43946 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -79251 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -68694 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -27483 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -25639 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -22307 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -150429 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -150.4K 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	Not reported	No source recorded
20182018-12-31	Operating cash flow	-43946	Operating Cash Flow: -43946 Open source
20192019-12-31	Operating cash flow	-79251	Operating Cash Flow: -79251 Open source
20202020-12-31	Operating cash flow	-68694	Operating Cash Flow: -68694 Open source
20212021-12-31	Operating cash flow	-27483	Operating Cash Flow: -27483 Open source
20222022-12-31	Operating cash flow	-25639	Operating Cash Flow: -25639 Open source
20232023-12-31	Operating cash flow	-22307	Operating Cash Flow: -22307 Open source
20242024-12-31	Operating cash flow	-150429	Operating Cash Flow: -150429 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	Unavailable	No source recorded
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -43946 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -79251 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -68694 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -27483 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -25639 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -22307 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -150429 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

6,450.4% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	130.7%	Total Liabilities: 25000 Open source Total Assets: 19134 Open source
20182018-12-31	Liabilities / assets	924.2%	Total Liabilities: 300320 Open source Total Assets: 32496 Open source
20192019-12-31	Liabilities / assets	4,044.1%	Total Liabilities: 375012 Open source Total Assets: 9273 Open source
20202020-12-31	Liabilities / assets	53,709.2%	Total Liabilities: 479623 Open source Total Assets: 893 Open source
20212021-12-31	Liabilities / assets	79,924.7%	Total Liabilities: 586647 Open source Total Assets: 734 Open source
20222022-12-31	Liabilities / assets	230,308.8%	Total Liabilities: 679411 Open source Total Assets: 295 Open source
20232023-12-31	Liabilities / assets	562,610.9%	Total Liabilities: 776403 Open source Total Assets: 138 Open source
20242024-12-31	Liabilities / assets	6,450.4%	Total Liabilities: 945884 Open source Total Assets: 14664 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	0.77×	Current Assets: 19134 Open source Current Liabilities: 25000 Open source
20182018-12-31	Current assets / current liabilities	0.11×	Current Assets: 31698 Open source Current Liabilities: 300320 Open source
20192019-12-31	Current assets / current liabilities	0.02×	Current Assets: 8761 Open source Current Liabilities: 375012 Open source
20202020-12-31	Current assets / current liabilities	0×	Current Assets: 667 Open source Current Liabilities: 479623 Open source
20212021-12-31	Current assets / current liabilities	0×	Current Assets: 734 Open source Current Liabilities: 586647 Open source
20222022-12-31	Current assets / current liabilities	0×	Current Assets: 295 Open source Current Liabilities: 679411 Open source
20232023-12-31	Current assets / current liabilities	0×	Current Assets: 138 Open source Current Liabilities: 776403 Open source
20242024-12-31	Current assets / current liabilities	0.02×	Current Assets: 14664 Open source Current Liabilities: 945884 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 95,568 Exact value Exact value: -95568 USD 2015-01-01 – 2015-12-31: -95568 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2015-12-31 BIOETHICS LTD (edgar:894560) Net Income: -95568 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -95568 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116317000060/bioe-20161231.xml#7719 Filing: 000155116317000060 The citation records this snapshot. The page link may show a newer release later.	−USD 36,981 Exact value Exact value: -36981 USD 2015-01-01 – 2015-12-31: -36981 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2015-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -36981 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36981 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116317000060/bioe-20161231.xml#13474 Filing: 000155116317000060 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	−USD 118,628 Exact value Exact value: -118628 USD 2016-01-01 – 2016-12-31: -118628 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2016-12-31 BIOETHICS LTD (edgar:894560) Net Income: -118628 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -118628 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116318000069/bioe-20171231.xml#8000 Filing: 000155116318000069 The citation records this snapshot. The page link may show a newer release later.	−USD 42,324 Exact value Exact value: -42324 USD 2016-01-01 – 2016-12-31: -42324 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2016-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -42324 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -42324 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116318000069/bioe-20171231.xml#10702 Filing: 000155116318000069 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 64,223 Exact value Exact value: -64223 USD 2017-01-01 – 2017-12-31: -64223 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2017-12-31 BIOETHICS LTD (edgar:894560) Net Income: -64223 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -64223 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116319000049/bioe-20181231.xml#6600 Filing: 000155116319000049 The citation records this snapshot. The page link may show a newer release later.	−USD 71,176 Exact value Exact value: -71176 USD 2017-01-01 – 2017-12-31: -71176 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2017-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -71176 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -71176 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116319000049/bioe-20181231.xml#9444 Filing: 000155116319000049 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 73,539 Exact value Exact value: -73539 USD 2018-01-01 – 2018-12-31: -73539 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2018-12-31 BIOETHICS LTD (edgar:894560) Net Income: -73539 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -73539 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116319000049/bioe-20181231.xml#6499 Filing: 000155116319000049 The citation records this snapshot. The page link may show a newer release later.	−USD 43,946 Exact value Exact value: -43946 USD 2018-01-01 – 2018-12-31: -43946 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2018-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -43946 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43946 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000155116320000019/both-20191231.xml#17963 Filing: 000155116320000019 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	Unavailable Not reported for this period.	−USD 79,251 Exact value Exact value: -79251 USD 2019-01-01 – 2019-12-31: -79251 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2019-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -79251 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -79251 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000109690621000773/both-20201231.htm#335535 Filing: 000109690621000773 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−USD 68,694 Exact value Exact value: -68694 USD 2020-01-01 – 2020-12-31: -68694 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2020-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -68694 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -68694 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000109690622000875/both-20211231.htm#318458 Filing: 000109690622000875 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	Unavailable Not reported for this period.	−USD 27,483 Exact value Exact value: -27483 USD 2021-01-01 – 2021-12-31: -27483 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2021-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -27483 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27483 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000109690623000832/both-20221231.htm#292965 Filing: 000109690623000832 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	Unavailable Not reported for this period.	−USD 25,639 Exact value Exact value: -25639 USD 2022-01-01 – 2022-12-31: -25639 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2022-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -25639 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25639 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000109690624000792/both-20231231.htm#314464 Filing: 000109690624000792 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 97,149 Exact value Exact value: -97149 USD 2023-01-01 – 2023-12-31: -97149 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2023-12-31 BIOETHICS LTD (edgar:894560) Net Income: -97149 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97149 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#521720 Filing: 000147793225005771 The citation records this snapshot. The page link may show a newer release later.	−USD 22,307 Exact value Exact value: -22307 USD 2023-01-01 – 2023-12-31: -22307 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2023-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -22307 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22307 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#444227 Filing: 000147793225005771 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 176,955 Exact value Exact value: -176955 USD 2024-01-01 – 2024-12-31: -176955 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOETHICS LTD · 2024-12-31 BIOETHICS LTD (edgar:894560) Net Income: -176955 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -176955 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#521190 Filing: 000147793225005771 The citation records this snapshot. The page link may show a newer release later.	−USD 150,429 Exact value Exact value: -150429 USD 2024-01-01 – 2024-12-31: -150429 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOETHICS LTD · 2024-12-31 BIOETHICS LTD (edgar:894560) Operating Cash Flow: -150429 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/894560/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -150429 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/894560/000147793225005771/both_10k.htm#443546 Filing: 000147793225005771 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

122 filings · 2,616 latest values · 2,616 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000894560, 894560, BIOE, BOTH, bioe, both, edgar:894560

Also known as BIOETHICS LTD, BIOETHICS, LTD, BIOETHICS, LTD.

BIOETHICS LTD

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation